Evidence map›Paper›PMID 34803281›Full record

ReviewThe Saudi dental journal2021

Laser as a promising non-invasive technique to treat oral submucous fibrosis: A systematic review of the literature.

Sonia Gupta, Manveen Kaur Jawanda

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Saudi dental journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Mechanistic Investigation of Curcuma Protection against Oral Submucous Fibrosis.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sonia GuptaDept. of Oral Pathology and Microbiology & Forensic odontology, Rayat Bahra Dental college and hospital, Mohali, Punjab, India.
Manveen Kaur JawandaDept. of Oral Pathology and Microbiology & Forensic odontology, Luxmi bai institute of dental sciences and hospital, Patiala, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral submucous fibrosis (OSMF) is one of the common oral potentially malignant disorders that can result in severe morbidity. Depending upon the stage of disease, multiple management therapies exist which include medicinal and surgical approaches. Although the surgical approach is preferred in severe conditions, numerous studies have reported its post-surgical deteriorating outcomes including increased fibrotic changes. To reduce these post-surgical complications, Light amplification by stimulated emission of radiation (Laser) has been introduced and studied as a non-invasive technique to treat oral submucous fibrosis. However, there exists a lack of knowledge about 'which laser shows a better post-treatment outcome'. Accordingly, this review aims to answer this question. MATERIALS AND

methodsA systematic review of the published literature was performed using an electronic search in PubMed/Medline, Science Direct, Web of Science, Embase, J- STAGE, Google Scholar, and Scopus databases, from 1952 till 2019 using keywords like, 'Oral submucous fibrosis', 'Treatment', 'Laser', 'Trismus', ' Fibrosis', 'Surgical', 'Non-invasive', and 'Postoperative results'.

resultsThe search strategy revealed 20 relevant published studies in which laser had been used to treat 250 patients of OSMF. Effective results were found without any complications in all the cases after follow up.

conclusionObserving the current literature, it can be concluded that laser might be used as a potential non-invasive approach in the management of OSMF, however, large scale studies are required to investigate the efficacy and other effects of this technology

Indexed as

AN, Areca nutcAMP, Cyclic adenosine monophosphateCO2, Carbon-dioxideCTGF/CCN2, Connective tissue growth factorEr Cr YS GG, Erbium Chromium: Yttrium – Scandium – Gallium – GarnetEr, YAG Erbium: Yttrium–Aluminium–GarnetGaAs, Gallium ArsenicGA, General anaesthesiaH2O, WaterHA, HydroxyapatiteIF- ά, Interferon άKTP, Potassium titanyl phosphateLA, Local anaesthesiaLaserLaser, Light amplification by stimulated emission of radiationLPLI, Low-power laser irradiationMMP2, Matrix metalloproteinases 2ND-YAG, Neodymium – doped: Yttrium- Aluminium GarnetNon-invasiveOral sub mucus fibrosisOSMF, Oral submucous fibrosisPGs, ProstaglandinsTechniqueTGF- β, Transforming Growth Factor βTNF, Tumor necrosis factorTreatmentUUO, Unilateral ureteral obstructionWHO, World Health Organization

Identifiers

PMID34803281
PMCPMC8589611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.